Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts Details-
Title Grant Type Focus Area Country Application Due Date Real World Evidence on the Impact of Early and Appropriate Use of Aztreonam-Avibactam (ATM-AVI)Release Date:Research Inflammation & Immunology Brazil, Chile, India, Italy, South Africa, Spain, United Kingdom Guideline Concordant Care and New Data for Patients with MIBC through la/mUCEducation Oncology USA Clinical Research Studies of Atirmociclib in HR+/HER2- and/or HER2+ Breast CancerRelease Date:Research Oncology Australia, Brazil, Canada, China, France, Germany, Italy, Japan, Korea, Mexico, Spain, Taiwan, USA, United Kingdom Quality Improvement Interventions to Enhance the Care of Patients Infected by MBL-CRE or S. maltophiliaRelease Date:Quality Improvement Inflammation & Immunology Australia, Chile, India, Italy, Spain, United Kingdom Advancing Real-World Evidence in Idiopathic Inflammatory Myopathies Through a German Disease RegistryRelease Date:Research Inflammation & Immunology Germany Real-World Evidence on Clinical Outcomes with ATM-AVI in Adult Patients with Stenotrophomonas maltophilia InfectionsRelease Date:Research Inflammation & Immunology China Real-World Evidence on Clinical Outcomes with Aztreonam-Avibactam (ATM-AVI) in Adult Patients with Limited Treatment OptionsRelease Date:Research Inflammation & Immunology China Tissue Penetration and Correlation with Clinical Outcomes of ATM-AVI in Adult Patients with Limited Treatment OptionsRelease Date:Research Inflammation & Immunology China Advancing Multidisciplinary Care in HemophiliaRelease Date:Quality Improvement Rare Disease China BCMA BsAb Educational Initiatives in 2L+ Relapsed/Refractory Multiple MyelomaRelease Date:Education Oncology USA -
Title Grant Type Focus Area Country Application Due Date Enhancing awareness and well understanding of the management in hypothalamic pituitary dysfunction, growth disordersRelease Date:Education Rare Disease Japan Long-acting Growth Hormone ResearchRelease Date:Research Rare Disease All COVID-19: Continuity in Care for Patients with Metastatic Breast Cancer Grant Support Program (United States and Europe)Release Date:Quality Improvement Oncology All 2020 Osteoarthritis and Osteoarthritis Pain- Virtual LearningEducation Internal Medicine All NASH – Future of Non-invasive Diagnosis TechnologiesRelease Date:Education Internal Medicine All Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Nurse NavigatorRelease Date:Quality Improvement Rare Disease USA Pfizer-ISID 2020 AFME Grant Challenge (Africa and the Middle East)Release Date:Partner:International Society for Infectious Diseases (ISID)
Quality Improvement Hospital All Advances in Oncology Therapy in Renal Cell CarcinomaRelease Date:Education Oncology Japan Increasing Awareness of Nuclear Scintigraphy in Cardiac AmyloidosisRelease Date:Education Rare Disease All Pfizer and RCNi – Providing Access to Learning Resources for Nurses in the APAC/China RegionRelease Date:Partner:RCNi (subsidiary of the Royal College of Nursing)
Education Internal Medicine Hong Kong, India, Indonesia, Malaysia, Pakistan, Philippines, Singapore, Taiwan, Thailand, Vietnam Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Latin AmericaRelease Date:Research Rare Disease Argentina, Brazil, Chile, Colombia Vaccine Preventable Diseases – COVID-19 (closed early)Release Date:Research Vaccines All